Anticoagulation for patients with atrial fibrillation receiving dialysis: a pilot randomized controlled trial
DOI:
文献链接:
其他信息:
Z Harel, B Smyth, SV Badve, D Blum…
Journal of the …, 2024
journals.lww.com
Background: Atrial fibrillation is common in individuals receiving dialysis. The role of oral anticoagulation in this population is uncertain given its exclusion from previous seminal clinical trials. Our objective was to determine the feasibility of performing a large definitive trial to establish the optimal anticoagulation strategy in individuals with atrial fibrillation receiving dialysis. Methods: The SAFE-D trial was a parallel-group, open-label, allocation-concealed, pilot randomized control trial that took place at 28 centres in Canada and …

